Kidney involvement in patients with severe and critical COVID-19
DOI:
https://doi.org/10.29193/RMU.39.2.4Keywords:
ACUTE KIDNEY INJURY, COVID-19Abstract
Introduction: acute renal injury was a frequently observed complication in critical patients during the COVID-19 pandemic.
Objectives: 1) to determine the incidence of acute renal injury associated to severe and critical COVID-19; 2) to determine prognostic implications in terms of mobimortality of renal involvement.
Method: prospective, observational and analytical study of a cohort of patients with severe and critical COVID-19 who were hospitalized in the Intensive Care Unit at Hospital Español. A descriptive and analytical study (single and multivariate) was performed using statistical significance level lower than 0.05.
Results: there were 233 patients with severe and critical COVID-19 hospitalized in the Intensive Care Unit at Hospital Español between September 9 and May 21. Acute renal injury associated to COVID-19: 47.9% (107/233), severe acute renal injury (stages KDIGO 2 and 3): 79.4% (85/107), nosocomial acute renal injury: 47.7% (52/107), acute renal injury: 41.1% (44/107), renal replacement techniques requirement: 29.9% (32/107).
Mortality upon discharge from Intensive Medicine in patients with acute renal injury was 72.9% (78/107), versus absence of acute renal injury: 48.4% (62/126) (p=0,000). The multivariate analysis showed normal renal function upon discharge from hospital was the protective predictive factor for death upon discharge from Intensive Medicine (OR 0,055, IC 95%: 0,014-0,213, p= 0,000).
Conclusions: incidence of acute renal injury associated to COVID-19 was high in Intensive Medicine, with predominance of stages 2-3, and it was related to a significantly higher mortality. Normalization of renal function was a protective predictive factor for the risk of death. The degree of multi-organ support was associated to a progressive increase of mortality.
References
Lamontagne F, Agarwal A, Rochwerg B, Siemieniuk RA, Agoritsas T, Askie L, et al. A living WHO guideline on drugs for covid-19. BMJ 2020; 370:m3379. doi: 10.1136/bmj.m3379.
Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, et al. COVID-19 associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020; 16(12):747-64. doi: 10.1038/s41581-020-00356-5.
Kidney Disease: improving global outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2(1):1-138.
Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 workgroup. Nat Rev Nephrol 2017; 13(4):241-57. doi: 10.1038/nrneph.2017.2.
Domecq JP, Lal A, Sheldrick CR, Kumar VK, Boman K, Bolesta S, et al. Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and Respiratory Illness Universal Study Registry. Crit Care Med 2021; 49(3):437-48. doi: 10.1097/CCM.0000000000004879.
Chan KW, Yu KY, Lee PW, Lai KN, Tang SC. Global REnal Involvement of CORonavirus Disease 2019 (RECORD): a systematic review and metaanalysis of incidence, risk factors, and clinical outcomes. Front Med (Lausanne) 2021; 8:678200. doi: 10.3389/fmed.2021.678200.
Palevsky PM. COVID-19 and AKI: Where do we stand? J Am Soc Nephrol 2021; 32(5):1029-32. doi: 10.1681/ASN.2020121768.
Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, et al. AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol 2021; 32(1):161-76. doi: org/10.1681/ASN.2020060897.
Estenssoro E, Loudet CI, Ríos FG, Kanoore Edul VS, Plotnikow G, Andrian M, et al. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. Lancet Respir Med 2021; 9(9):989-98. doi: 10.1016/S2213-2600(21)00229-0.
Moledina DG, Simonov M, Yamamoto Y, Alausa J, Arora T, Biswas A, et al. The association of COVID-19 with acute kidney injury independent of severity of illness: a multicenter cohort study. Am J Kidney Dis 2021; 77(4):490-9.e1. doi: 10.1053/j.ajkd.2020.12.007.
Chebotareva N, Berns S, Berns A, Androsova T, Lebedeva M, Moiseev S. Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients. Kidney Res Clin Pract 2021; 40(2):241-9. doi: 10.23876/j.krcp.20.128.
Lu JY, Babatsikos I, Fisher MC, Hou W, Duong TQ. Longitudinal clinical profiles of hospital vs. community-acquired acute kidney injury in COVID-19. Front Med (Lausanne) 2021; 8:647023. doi: 10.3389/fmed.2021.647023.
Matsumoto K, Prowle JR. COVID-19-associated AKI. Curr Opin Crit Care 2022; 28(6):630-7. doi: 10.1097/MCC.0000000000000988.
Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and metaanalysis. Crit Care 2020; 24(1):356. doi: 10.1186/s13054-020-03065-4.
Silver SA, Beaubien-Souligny W, Shah PS, Harel S, Blum D, Kishibe T. The prevalence of acute kidney injury in patients hospi-talized with COVID-19 infection: a systematic review and metaanalysis. Kidney Med 2021; 3(1):83-98.e1. doi: 10.1016/j.xkme.2020.11.008.
Yang X, Tian S, Guo H. Acute kidney injury and renal re-placement therapy in COVID-19 patients: a systematic review and metaanalysis. Int Immunopharmacol 2021; 90:107159. doi: 10.1016/j.intimp.2020.107159.
Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kid Int 2020; 98(1):209-18. doi: 10.1016/j.kint.2020.05.006.
Feng YF, Wang KP, Mo JG, Xu YH, Wang LZ, Jin C, et al. The spatiotemporal trend of renal involvement in COVID-19: a pooled analysis of 17 134 patients. Int J Infect Dis 2021; 106:281-8. doi: 10.1016/j.ijid.2021.03.082.
Bowe B, Cai M, Xie Y, Gibson AK, Maddukuri G, Al-Aly Z. Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19. Clin J Am Soc Nephrol 2020; 16(1):14-25. doi: 10.2215/CJN.09610620.
Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021; 17(11):751-64. doi: 10.1038/s41581-021-00452-0.
Charytan DM, Parnia S, Khatri M, Petrilli CM, Jones S, Benstein J, et al. Decreasing incidence of acute kidney injury in patients with COVID-19 critical illness in New York City. Kidney Int Rep 2021; 6(4):916-27. doi: 10.1016/j.ekir.2021.01.036.
Endre ZH, Mehta RL. Identification of acute kidney injury subphenotypes. Curr Opin Crit Care 2020; 26(6):519-24. doi: 10.1097/MCC.0000000000000772.
Rao A, Ranka S, Ayers C, Hendren N, Rosenblatt A, Alger HM, et al. Association of Kidney Disease with outcomes in COVID-19: results from the American Heart Association COVID-19 Cardiovas-cular Disease Registry. J Am Heart Assoc 2021; 10(12):e020910. doi: 10.1161/JAHA.121.020910.
Bezerra R, Teles F, Mendonca PB, Damte T, Likaka A, Ferrer-Miranda E, et al. Outcomes of critically ill patients with acute kidney injury in COVID-19 infection: an observational study. Ren Fail 2021; 43(1):911-8. doi: 10.1080/0886022X.2021.1933530.
Menon T, Sharma R, Kataria S, Sardar S, Adhikari R, Tousif S, et al. The association of acute kidney injury with disease severity and mortality in COVID-19: a systematic review and metaanalysis. Cureus 2021; 13(3):e13894. doi: 10.7759/cureus.13894.
Lin L, Wang X, Ren J, Sun Y, Yu R, Li K, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a metaanalysis. BMJ Open 2020; 10(11):e042573. doi: 10.1136/bmjopen-2020-042573.
Birkelo BC, Parr SK, Perkins AM, Greevy RA Jr, Hung AM, Shah SC, et al. Comparison of COVID-19 versus influenza on the incidence, features, and recovery from acute kidney injury in hospitalized United States Veterans. Kidney Int 2021; 100(4):894-905. doi: 10.1016/j.kint.2021.05.029.
Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med 2021; 385(12):1078-90. doi: 10.1056/NEJMoa2110475.
